Digitally enabled therapies for adults with depression: early value assessment (HTE8)Product type:GuidanceProgramme:Health technology evaluationLast updated: 12 February 2024Published: 16 May 2023
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal) (TA899)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 June 2023
Esketamine nasal spray for treatment-resistant depression (TA854)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2022
Depression in adults: treatment and management (NG222)Product type:GuidanceProgramme:NICE guidelinePublished: 29 June 2022
Implanted vagus nerve stimulation for treatment-resistant depression (IPG679)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 12 August 2020
Depression in children and young people: identification and management (NG134)Product type:GuidanceProgramme:NICE guidelinePublished: 25 June 2019
Repetitive transcranial magnetic stimulation for depression (IPG542)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 December 2015
Vortioxetine for treating major depressive episodes (TA367)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 November 2015
Transcranial direct current stimulation (tDCS) for depression (IPG530)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 August 2015
Agomelatine for the treatment of major depressive episodes (terminated appraisal) (TA231)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 July 2011
Depression in adults with a chronic physical health problem: recognition and management (CG91)Product type:GuidanceProgramme:Clinical guidelinePublished: 28 October 2009
Depression in adults (QS8)Product type:Quality standardLast updated: 29 June 2023Published: 29 March 2011
Depression in children and young people (QS48)Product type:Quality standardPublished: 30 September 2013
Zuranolone for treating severe postnatal depression ID6431Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC